Continuous increase of cardiovascular diseases, diabetes, and non-HIV related cancers as causes of death in HIV-infected individuals in Brazil: an analysis of nationwide data

PLoS One. 2014 Apr 11;9(4):e94636. doi: 10.1371/journal.pone.0094636. eCollection 2014.

Abstract

Introduction: After antiretroviral therapy (ART) became available, there was a decline in the number of deaths in persons infected with HIV. Thereafter, there was a decrease in the proportion of deaths attributed to opportunistic infections and an increase in the proportion of deaths attributed to chronic comorbidities. Herein we extend previous observations from a nationwide survey on temporal trends in causes of death in HIV-infected patients in Brazil.

Methods: We describe temporal trends in causes of death among adults who had HIV/AIDS listed in the death certificate to those who did not. All death certificates issued in Brazil from 1999 to 2011 and listed in the national mortality database were included. Generalized linear mixed-effects logistic models were used to study temporal trends in proportions.

Results: In the HIV-infected population, there was an annual adjusted average increase of 6.0%, 12.0%, 4.0% and 4.1% for cancer, external causes, cardiovascular diseases (CVD) and diabetes mellitus (DM), respectively, compared to 3.0%, 4.0%, 1.0% and 3.9%, in the non-HIV group. For tuberculosis (TB), there was an adjusted average increase of 0.3%/year and a decrease of 3.0%/year in the HIV and the non-HIV groups, respectively. Compared to 1999, the odds ratio (OR) for cancer, external causes, CVD, DM, or TB in the HIV group were, respectively, 2.31, 4.17, 1.76, 2.27 and 1.02, while for the non-HIV group, the corresponding OR were 1.31, 1.63, 1.14, 1.62 and 0.67. Interactions between year as a continuous or categorical variable and HIV were significant (p<0.001) for all conditions, except for DM when year was considered as a continuous variable (p = 0.76).

Conclusions: Non HIV-related co-morbidities continue to increase more rapidly as causes of death among HIV-infected individuals than in those without HIV infection, highlighting the need for targeting prevention measures and surveillance for chronic diseases among those patients.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Brazil / epidemiology
  • Cardiovascular Diseases / complications*
  • Cardiovascular Diseases / epidemiology
  • Cause of Death*
  • Diabetes Mellitus / epidemiology
  • Female
  • HIV Infections / complications*
  • HIV Infections / epidemiology
  • HIV Infections / mortality*
  • Humans
  • Male
  • Middle Aged
  • Odds Ratio
  • Public Health Surveillance
  • Young Adult

Grants and funding

This work was supported by Fundação de Amparo à Pesquisa do Estado do Rio de Janeiro/FAPERJ (www.faperj.br); Conselho Nacional de Desenvolvimento Científico e Tecnológico/CNPq (www.cnpq.br) and Coordenação de Aperfeiçoamento de Pessoal de Nível Superior/Capes (www.capes.gov.br). GlaxoSmithKline Group provided support in the form of a salary for author SHT (for part of the duration of this study), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.